MRK Financial Facts

Other (income) expense, net: -3.28B
Research and development: 5.14B
See Full Income Statement

Trade accounts payable: 646.8M
Total Merck & Co., Inc. stockholders' equity: 15.87B
See Full Balance Sheet

Merck & Co. Inc. (MRK) Earnings

  |   Expand Research on MRK
Next EPS Date 2/5/15 *Est. EPS Growth Rate -2.2% *Last Qtr.
Average EPS % Beat Rate +5.0% Revenue Growth Rate -4.3% *Last Qtr.
Average % Move 1-Wk after EPS +1.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/27/14 Q314 $0.90$0.88 +$0.02$10.56B$10.66B = Details
7/29/14 Q214 $0.85$0.80 +$0.05$10.93B$10.6B = Details
4/29/14 Q114 $0.88$0.79 +$0.09$10.3B$10.44B = Details
2/5/14 Q413 $0.88$0.88 $0.00$11.3B$11.39B = Details
10/28/13 Q313 $0.92$0.87 +$0.05$11.03B$11.19B = Details
7/30/13 Q213 $0.84$0.82 +$0.02$11.01B$11.22B = Details
5/1/13 Q113 $0.85$0.79 +$0.06$10.7M$11.09M = Details
2/1/13 Q412 $0.83$0.81 +$0.02$11.7B$11.46B = Details